7-Epi-10-oxo-docetaxel is primarily explored for its potential in cancer treatment, particularly as a chemotherapeutic agent. It is structurally related to docetaxel, a well-known anticancer drug, and shares similar mechanisms of action. This compound works by stabilizing microtubules, preventing their disassembly, and thereby inhibiting cell division. This makes it effective in targeting rapidly dividing cancer cells. Research is ongoing to evaluate its efficacy, safety, and potential advantages over existing taxane-based therapies, especially in treating resistant or advanced cancers. It may also be studied in combination with other drugs to enhance therapeutic outcomes.